scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1044492614 |
P356 | DOI | 10.1007/S11912-011-0196-6 |
P698 | PubMed publication ID | 21931938 |
P2093 | author name string | Kim Margolin | |
P2860 | cites work | Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens | Q24644442 |
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 | Q29616128 | ||
New insights into the regulation of T cells by gamma(c) family cytokines | Q33623326 | ||
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit | Q34601772 | ||
Optimising the conditioning regimen for acute myeloid leukaemia | Q37644054 | ||
P433 | issue | 6 | |
P304 | page(s) | 427-429 | |
P577 | publication date | 2011-12-01 | |
P1433 | published in | Current Oncology Reports | Q2264969 |
P1476 | title | Adoptive T-cell therapy of melanoma using designer T-cell receptors | |
P478 | volume | 13 |